Cyrus M.

Cyrus M. serves as Chief Executive Officer at both NovaCina and LumaCina, overseeing organizations that specialize in the development and manufacturing of sterile injectable drug products with a focus on quality and safety. Additionally, Cyrus holds the position of Chairman and Managing Partner at Bioselective Capital Investments while advising for Advent International and Bridgewest Ventures NZ. With previous roles as Director and Board Member at BioOra and extensive experience at BioDuro-Sundia and Formex, Cyrus has been influential in advancing drug development and manufacturing processes. Cyrus is also an alumnus of UC Irvine, where a Bachelor of Science in Biology was earned.